RELEASE DATE: July 31, 2020
EXPIRATION DATE: July 31, 2021
Credit Available
- Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s)
- Nurses — 1.5 Contact Hours
- Pharmacists – 1.5 Contact Hours
All other health care professionals completing this course will be issued a statement of participation.
Target Audience
This activity is intended for neurology and primary care physicians, nurse practitioners, PAs, nurses, pharmacists, rehabilitation specialists, mental health professionals, and other members of the healthcare team essential to the care of patients living with MS.
Learning Objectives
- Review the history of and current known facts related to COVID-19
- Describe the risks of COVID-19 in people living with MS
- Discuss opportunities for care and best practices for implementation of telemedicine for people living with MS
- Employ best practices for implementation of telemedicine in MS management
Faculty
Edward J. Fox, MD, PhD (Chairperson)
Director, MS Clinic of Central Texas
Central Texas Neurology Consultants, PA
Clinical Associate Professor, University of Texas Dell Medical School
Stephanie Agrella, PhDc, MSN, RN, ANP-BC, MSCN
Director of Clinical Services
Multiple Sclerosis Clinic of Central Texas
Joseph R. Berger, MD, FACP, FAAN, FANA
Professor of Neurology and Associate Chief of the MS Division
Perelman School of Medicine
University of Pennsylvania
Frederick W. Foley, PhD
Professor of Psychology, Yeshiva University, Ferkauf Graduate School of Psychology
Director of Neuropsychology and Psychosocial Research, Holy Name Medical Center Multiple Sclerosis Center
Supported by an educational grant from Novartis Pharmaceuticals Corporation.